Background: Respiratory diseases remain among the top five leading causes of morbidity, with an incidence rate of 788.4 cases per 10,000 population in 2021. Among these, acute bronchitis accounts for 9.3%. According to international clinical guidelines for the diagnosis and treatment of adult acute bronchitis, symptoms usually resolve spontaneously within 1–3 weeks, but they considerably reduce the patient’s quality of life. Therefore, Colsaurin syrup, a new natural formulation with analgesic and anti-inflammatory effects, was clinically investigated to assess its efficacy and safety. The introduction of this domestically produced herbal medicine into clinical practice is expected to have both medical and socioeconomic significance by expanding the range of national pharmaceutical products. Aim: To evaluate the effect of Colsaurin syrup on the quality of life in adults diagnosed with acute bronchitis. Materials and Methods: This study was a randomized, double-blind, placebo-controlled clinical trial conducted among inpatients at Songinokhairkhan District General Hospital, Ulaanbaatar. Adult patients diagnosed with acute bronchitis (J20) who met the inclusion criteria and provided informed consent were enrolled. Participants were randomly assigned to either the Colsaurin or placebo group. Result: In the Bronchitis Severity Score (BBS) assessment, baseline mean scores indicated severe disease: 10.88±2.47 in the Colsaurin group and 10.67±2.16 in the placebo group. After treatment, scores decreased significantly to 3.50±1.41 (p<0.001) in the Colsaurin group and 5.00±2.24 (p=0.006) in the placebo group, indicating greater improvement in the Colsaurin-treated patients. In the Visual Analog Scale (VAS) assessment, the mean pre-treatment score for both groups was 7, corresponding to frequent cough, which decreased to 2 after treatment (p<0.05), representing a 28% reduction in coughing discomfort. In the Cough and Sputum Assessment Questionnaire (CASA-Q), the Colsaurin group showed a 3.25-point reduction after treatment, indicating a significant decrease in cough frequency and triggering factors (p<0.05). Conclusion 1. In patients diagnosed with acute bronchitis (J20), treatment with Colsaurin syrup reduced disease severity by 30% and alleviated cough-related discomfort by 28% compared to baseline. 2. Moreover, patients reported improved sleep quality and work capacity, reflecting an overall enhancement in quality of life. 3. No adverse effects were observed in the Colsaurin treatment group.

Background: In recent years, due to the rapid development of digital technology and the decline in physical activity, there has been a noticeable decrease in the physical development of children and adolescents, along with an increased risk of non-communicable diseases. Organizations such as the World Health Organization, UNESCO, and the International Olympic Committee recommend integrating regular physical activity into daily life to promote population health. Therapeutic physical exercise is an effective method for restoring bodily functions, increasing muscle strength, and correcting movement impairments, and it serves as an important tool for supporting the physical development and health of school-aged children. Therefore, this study aimed to determine the effects of therapeutic physical exercise on the physical development indicators of children with chronic illnesses and disabilities. Aim: To determine the impact and effectiveness of inclusive participation of students with pathological conditions in physical education classes on their physical development and health indicators. Materials and Methods: Thirty students diagnosed with chronic diseases and enrolled in general education schools participated voluntarily. At the beginning of the study, demographic information was collected, and baseline measurements were taken to assess flexibility, waist and hip circumference, forearm and back muscle strength. Therapeutic exercises tailored to the characteristics of each condition were then implemented according to the FITT principle. After the intervention period, follow-up measurements were conducted. Data were analyzed using descriptive statistics, paired t-test, independent t-test, Pearson correlation, and Cohen’s d in SPSS 25.0 software. Statistical significance was evaluated at the p<0.05 level. Results: After the therapeutic exercise intervention, participants’ flexibility increased by 3.70 cm, right-hand muscle strength by 7.50 kg, left-hand muscle strength by 6.92 kg, and back muscle strength by 17.60 kg, all of which were statistically significant changes (p<0.05). Height increased by 2.36 cm and weight by 1.98 kg. The effect sizes of these indicators ranged from moderate to high. Conclusions 1. The results of this study demonstrate that therapeutic exercise may produce statistically significant positive changes in certain physical fitness parameters among students with pathological conditions, particularly in upper limb and back muscle strength, as well as flexibility. The observed effect sizes ranged from moderate to high, indicating potential practical significance for implementation in practice. 2. In contrast, the changes observed in height and body weight are considered to reflect the indirect effects of therapeutic exercise together with the participants’ natural physiological growth and development. 3. This study suggests that therapeutic exercise may serve as an effective approach for promoting inclusive participation in educational activities among students who are exempted from regular physical education classes, while also supporting the improvement of their physical capacity.